On Sept. 12, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Sept. 11, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
CBP said the FDA will hold an extended downtime from Sept. 13 10 p.m. through 6 a.m. Sept. 14 ET as the agency installs a critical security update, according to a Sept. 12 cargo systems message.
On Sept. 10, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Sept. 8, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Sept. 5, the FDA posted new and revised versions of the following Import Alerts (after not having posted new ones for a number of days) on the detention without physical examination of:
The FDA is developing a list, called a "green list," aimed at preventing the importation of glucagon-like peptide-1 (GLP-1) active pharmaceutical ingredients (APIs) from unverified foreign sources, according to an agency release.
On Sept. 4, the FDA posted new and revised versions of the following Import Alerts (after not having posted new ones for a number of days) on the detention without physical examination of:
On Sept. 3, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Sept. 2, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of: